照护利用模式与肝细胞癌监测:追踪疫情期间的照护变化
在2020至2021年退伍军人事务部全国肝硬化队列中,评估门诊、住院、死亡及肝细胞癌监测趋势。疫情期间门诊预约率初期从30%降至7%后回升,远程医疗月度就诊率从不足10%峰值20%后逐渐下降。肝细胞癌监测完成率疫情前近70%,早期低谷约50%,两年后为60%。基于人群的肝硬化仪表板和专科就诊与更高的监测完成率相关。
要点
- 疫情期间门诊预约率初期从30%降至7%后回升,远程医疗月度就诊率峰值20%后逐渐下降。
- 肝细胞癌监测完成率疫情前近70%,早期低谷约50%,两年后为60%。
- 基于人群的肝硬化仪表板和消化科/肝病科就诊与更高监测完成率相关。
核心结论
- 门诊利用和肝细胞癌监测率已回升但仍低于基线水平。
- 基于人群的方法和肝硬化专科照护与更高的肝细胞癌监测完成率相关。
研究设计与样本
- 研究为2020至2021年退伍军人事务部全国肝硬化队列,共纳入68073例,其中28678例符合肝细胞癌监测条件。
主要发现
- 门诊初级保健提供者和消化科/肝病科预约率初期从30%降至7%,疫情一年后回升并随后稳定。
- 远程医疗月度就诊率从不足10%升至峰值20%,随后逐渐下降。
- 肝细胞癌监测完成率疫情前近70%,早期低谷约50%,疫情两年后为60%。
- 调整模型中,使用基于人群的肝硬化仪表板(β 8.5,95% CI 6.9-10.2)、面对面消化科/肝病科就诊(β 3.2,95% CI 2.9-3.6)和远程医疗消化科/肝病科就诊(β 2.1,95% CI 1.9-2.4)均与更高的监测完成率相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: We studied longitudinal trends in mortality, outpatient, and inpatient care for cirrhosis in a national cohort in the first 2 years of the coronavirus disease-2019 pandemic. We evaluated trends in hepatocellular carcinoma (HCC) surveillance and factors associated with completion. METHODS: Within the national cirrhosis cohort in the Veterans Administration from 2020 to 2021, we captured mortality, outpatient primary care provider, gastroenterology/hepatology (GI/HEP) visits, and hospitalizations. HCC surveillance was computed as percentage of time up to date with surveillance every 6 months (PTUDS). Multivariable models for PTUDS were adjusted for patient demographics, clinical factors, and facility-level variables. RESULTS: The total cohort was 68,073; 28,678 were eligible for HCC surveillance. Outpatient primary care provider and GI/HEP appointment rates initially dropped from 30% to 7% with a rebound 1 year into the pandemic and steady subsequent use. Telemedicine monthly visit rates rose from less than 10% to a peak of 20% with a steady gradual decline. Nearly 70% of Veterans were up to date with HCC surveillance before the pandemic with an early pandemic nadir of approximately 50% and 60% PTUDS 2 years into the pandemic. In adjusted models, use of a population-based cirrhosis dashboard (β 8.5, 95% CI 6.9-10.2) and GI/HEP visits both in-person (β 3.2, 95% CI 2.9-3.6) and telemedicine (β 2.1, 95% CI 1.9-2.4) were associated with a higher PTUDS. DISCUSSION: Outpatient utilization and HCC surveillance rates have rebounded but remain below at baseline. Population-based approaches and specialty care for cirrhosis were associated with a higher completion of HCC surveillance.
引用
- Serper M, Tapper EB, Kaplan DE, et al. Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic. Am J Gastroenterol. 2022. PMID: 36114778. doi:10.14309/ajg.0000000000002011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。